Modulation of lymphocytotoxic activity in highly sensitised patients by anti-idiotypic antibodies.
MacLeod
A M
AM
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, United Kingdom.
al-Muzairai
I A
IA
Innes
A
A
Power
D A
DA
Stewart
K N
KN
Catto
G R
GR
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D003601:Cytotoxicity Tests, Immunologic; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D015395:Histocompatibility Antigens Class I; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007130:Immunoglobulin Idiotypes